Financing & Investment

MedNews is a FREE SERVICE of Medical and Pharma Insider in conjunction with BCI News Service.

To have your company news featured at Medical and Pharma Insider, please visit www.bcinewsservice.com.

View our disclaimer/disclosure

Featuring MedNews and MedTalks Videos, video conversations with management of medical, pharma, biopharma, healthcare, telemedicine, and medical device companies.

1 day ago
5 min

Alleviant Medical raises $75 million for clinical trials of novel technology to treat heart failure

Alleviant’s mission is to bring a safe, effective no-implant treatment option to millions of patients suffering from heart failure.

May 22
6 min

Startups Wanted: Catalyst by Wellstar Launches $100 Million Fund to Shape Future of Healthcare

Wellstar will directly influence the problems addressed and solutions created by the nation's most promising startups and entrepreneurs.

May 19
3 min

Acurx Pharmaceuticals prices $4 million placement to advance its new class of antibiotics

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

May 18
6 min

HealthSnap closes $9 Million for its remote patient monitoring and chronic care management platform

HealthSnap is an integrated virtual care management platform that helps healthcare organizations improve patient outcomes...

May 15
2 min

Sealonix raises $20 Million to develop sealants for abdominopelvic and orthopedic procedures

The PramStat patch builds on many years of research done by this experienced team, and now will move rapidly into clinical development.

May 12
6 min

Regentis Biomaterials to become listed on Nasdaq through a SPAC transaction

Regentis’ current efforts are focused on orthopedic treatments using its Gelrin platform based on resorbable hydrogel implants to regenerate

May 11
3 min

Lexaria Bioscience prices $2 million public offering - proceeds to advance drug delivery technology

DehydraTECH evidenced an ability to deliver some drugs more effectively across the blood brain barrier.

May 6
6 min

MultiOmic Health Closes $6.2 Million for precision medicines for metabolic syndrome conditions

The proceeds of this financing will be used to demonstrate proof-of-concept for MultiOmic’s MOHSAIC platform in diabetic kidney disease

May 5
3 min

Galmed Pharmaceuticals and OnKai partner for clinical studies in underserved communities

Through this partnership, the companies intend to facilitate faster clinical trial enrollment and provide patients with access to medicines

May 4
4 min

Magenta Medical raises $55 million to advance the world's smallest heart pump

Magenta's Elevate™ percutaneous left ventricular assist device is currently in clinical testing

Apr 27
4 min

Mezzion Pharma raises $40 million for its first-to-market treatment for fontan patients

The average life expectancy for a Fontan patient is 35-45 and apart from JURVIGO, there are currently no other pharmacotherapies available

Apr 20
3 min

Singapore-based Ross Swan joins FC Global Strategies as Managing Director, Asia-Pacific

Medical and Pharma Insider is a program of FC Global Strategies.

Apr 19
2 min

Medical device company, BioVentrix closes on $48.5 million to improve cardiac function

BioVentrix is a medical device company focused on the development of less invasive therapies to treat the failing left ventricle.

Apr 18
4 min

Aer Therapeutics raises $36 Million to advance development of a mucolytic for lung diseases

Aer Therapeutics is a clinical stage biopharmaceutical company with a mission to develop novel treatments for mucus-associated lung diseases

Apr 17
3 min

Professional Health Care Network rebrands as "Tango" and expands its strategic partnerships

Tango's services provide higher quality care, improved access, better patient outcomes, and reduced total costs...

Apr 14
4 min

Novo Holdings participates in $105 million funding in Alentis Therapeutics

Alentis Therapeutics is a biotechnology company that focuses on developing treatments for CLDN1+ tumors and organ fibrosis.

Mar 30
3 min

Viking Therapeutics prices $250 Million public common stock offering

Viking Therapeutics is a clinical-stage biopharmaceutical company that is developing novel first-in-class or best-in-class therapies

Mar 28
3 min

EpiBiologics raises $50 million for next-generation antibody-based protein degradation platform

EpiBiologics is building a next-generation protein degradation platform that targets membrane and extracellular proteins.

Mar 27
3 min

Reveal HealthTech raises $4 million to provide healthcare organizations with engineering support

Reveal HealthTech provides specialized engineering, clinical model, and strategy support to healthcare organizations in the US and worldwide

Mar 24
2 min

The healthcare revenue cycle management (RCM) technology company Janus receives strategic investment

With Janus' technology, companies can generate as high as a 2% increased net revenue and reduction of costs of collection by as much as 35%.